
Reset all filters
01 1AstraZeneca Canada Inc.
Reset all filters
01 12600434
Reset all filters
01 1TREMELIMUMAB
Reset all filters
01 1SOLUTION
Reset all filters
01 12026-03-02
Patent Expiration Date : 2026-03-02
Date Granted : 2017-09-19
Brand Name : IMJUDO
Patent Number : 2600434
Filing Date : 2006-03-02
Strength per Unit : 20 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2026-03-02
Date Granted : 2017-09-19
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF